Intrinsic Value
BioCryst Pharmaceuticals, Inc. (BCRX)
$8.46
-0.04 (-0.47%)
| Enterprise Value | -2,149,003.29 |
|---|---|
| Net Debt | 436.69 |
| Equity Value | -2,149,439.97 |
| Shares Outstanding | 179.12 |
| Equity Value Per Share | -12,000.20 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt